Genocea Biosciences, Inc.

Quick facts

Phase 2 pipeline

• GEN-004 with Aluminum Hydroxide Adjuvant · Oncology
  GEN-004 is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack tumor-associated antigens expressed on cancer cells.
• Streptococcus pneumoniae inoculation

Phase 1 pipeline

• GEN-003 with Matrix M-2
• GEN-004 High Dose
• GEN-004 Low Dose
• GEN-004 Mid Dose
• GEN-009 Adjuvanted Vaccine

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Genocea Biosciences, Inc. portfolio CI brief
• Genocea Biosciences, Inc. pipeline updates RSS